BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1254 related articles for article (PubMed ID: 27217345)

  • 1. Adipose Mesenchymal Stromal Cell-Based Therapy for Severe Osteoarthritis of the Knee: A Phase I Dose-Escalation Trial.
    Pers YM; Rackwitz L; Ferreira R; Pullig O; Delfour C; Barry F; Sensebe L; Casteilla L; Fleury S; Bourin P; Noël D; Canovas F; Cyteval C; Lisignoli G; Schrauth J; Haddad D; Domergue S; Noeth U; Jorgensen C;
    Stem Cells Transl Med; 2016 Jul; 5(7):847-56. PubMed ID: 27217345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intra-articular injection of mesenchymal stem cells for the treatment of osteoarthritis of the knee: a proof-of-concept clinical trial.
    Jo CH; Lee YG; Shin WH; Kim H; Chai JW; Jeong EC; Kim JE; Shim H; Shin JS; Shin IS; Ra JC; Oh S; Yoon KS
    Stem Cells; 2014 May; 32(5):1254-66. PubMed ID: 24449146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intra-Articular Injection of Autologous Adipose Tissue-Derived Mesenchymal Stem Cells for the Treatment of Knee Osteoarthritis: A Phase IIb, Randomized, Placebo-Controlled Clinical Trial.
    Lee WS; Kim HJ; Kim KI; Kim GB; Jin W
    Stem Cells Transl Med; 2019 Jun; 8(6):504-511. PubMed ID: 30835956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intra-articular Injection of Autologous Adipose-Derived Stem Cells or Stromal Vascular Fractions: Are They Effective for Patients With Knee Osteoarthritis? A Systematic Review With Meta-analysis of Randomized Controlled Trials.
    Kim KI; Kim MS; Kim JH
    Am J Sports Med; 2023 Mar; 51(3):837-848. PubMed ID: 35019764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intra-articular implantation of autologous bone marrow-derived mesenchymal stromal cells to treat knee osteoarthritis: a randomized, triple-blind, placebo-controlled phase 1/2 clinical trial.
    Emadedin M; Labibzadeh N; Liastani MG; Karimi A; Jaroughi N; Bolurieh T; Hosseini SE; Baharvand H; Aghdami N
    Cytotherapy; 2018 Oct; 20(10):1238-1246. PubMed ID: 30318332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Efficacy of Intra-articular Mesenchymal Stromal Cells for the Treatment of Knee Osteoarthritis: A Double-Blinded Prospective Randomized Controlled Clinical Trial.
    Garza JR; Campbell RE; Tjoumakaris FP; Freedman KB; Miller LS; Santa Maria D; Tucker BS
    Am J Sports Med; 2020 Mar; 48(3):588-598. PubMed ID: 32109160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Efficacy and Safety of the Intra-articular Injection of Autologous Adipose-Derived Mesenchymal Stem Cells for Knee Osteoarthritis: A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial.
    Kim KI; Lee MC; Lee JH; Moon YW; Lee WS; Lee HJ; Hwang SC; In Y; Shon OJ; Bae KC; Song SJ; Park KK; Kim JH
    Am J Sports Med; 2023 Jul; 51(9):2243-2253. PubMed ID: 37345256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intra-articular infiltration of adipose-derived stromal vascular fraction cells slows the clinical progression of moderate-severe knee osteoarthritis: hypothesis on the regulatory role of intra-articular adipose tissue.
    Lapuente JP; Dos-Anjos S; Blázquez-Martínez A
    J Orthop Surg Res; 2020 Apr; 15(1):137. PubMed ID: 32272946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intra-articular Injection of Mesenchymal Stem Cells for the Treatment of Osteoarthritis of the Knee: A 2-Year Follow-up Study.
    Jo CH; Chai JW; Jeong EC; Oh S; Shin JS; Shim H; Yoon KS
    Am J Sports Med; 2017 Oct; 45(12):2774-2783. PubMed ID: 28746812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intra-articular injection of autologous adipose-derived stromal vascular fractions for knee osteoarthritis: a double-blind randomized self-controlled trial.
    Hong Z; Chen J; Zhang S; Zhao C; Bi M; Chen X; Bi Q
    Int Orthop; 2019 May; 43(5):1123-1134. PubMed ID: 30109404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intra-articular injection of two different doses of autologous bone marrow mesenchymal stem cells versus hyaluronic acid in the treatment of knee osteoarthritis: multicenter randomized controlled clinical trial (phase I/II).
    Lamo-Espinosa JM; Mora G; Blanco JF; Granero-Moltó F; Nuñez-Córdoba JM; Sánchez-Echenique C; Bondía JM; Aquerreta JD; Andreu EJ; Ornilla E; Villarón EM; Valentí-Azcárate A; Sánchez-Guijo F; Del Cañizo MC; Valentí-Nin JR; Prósper F
    J Transl Med; 2016 Aug; 14(1):246. PubMed ID: 27565858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Umbilical Cord-Derived Mesenchymal Stromal Cells (MSCs) for Knee Osteoarthritis: Repeated MSC Dosing Is Superior to a Single MSC Dose and to Hyaluronic Acid in a Controlled Randomized Phase I/II Trial.
    Matas J; Orrego M; Amenabar D; Infante C; Tapia-Limonchi R; Cadiz MI; Alcayaga-Miranda F; González PL; Muse E; Khoury M; Figueroa FE; Espinoza F
    Stem Cells Transl Med; 2019 Mar; 8(3):215-224. PubMed ID: 30592390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety, tolerability and efficacy of intra-articular Progenza in knee osteoarthritis: a randomized double-blind placebo-controlled single ascending dose study.
    Kuah D; Sivell S; Longworth T; James K; Guermazi A; Cicuttini F; Wang Y; Craig S; Comin G; Robinson D; Wilson J
    J Transl Med; 2018 Mar; 16(1):49. PubMed ID: 29510712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and Tolerability of Intra-Articular Injection of Adipose-Derived Mesenchymal Stem Cells GXCPC1 in 11 Subjects With Knee Osteoarthritis: A Nonrandomized Pilot Study Without a Control Arm.
    Chen CF; Chen YC; Fu YS; Tsai SW; Wu PK; Chen CM; Chen WM; Wu HH; Lee CH; Chang CL; Lin PC; Kao YC; Chen CH; Chuang MH
    Cell Transplant; 2024; 33():9636897231221882. PubMed ID: 38205679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Phase I Dose-Escalation Clinical Trial to Assess the Safety and Efficacy of Umbilical Cord-Derived Mesenchymal Stromal Cells in Knee Osteoarthritis.
    Matas J; García C; Poblete D; Vernal R; Ortloff A; Luque-Campos N; Hidalgo Y; Cuenca J; Infante C; Cadiz MI; Khoury M; Luz-Crawford P; Espinoza F
    Stem Cells Transl Med; 2024 Mar; 13(3):193-203. PubMed ID: 38366909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative Clinical Outcomes After Intra-articular Injection With Adipose-Derived Cultured Stem Cells or Noncultured Stromal Vascular Fraction for the Treatment of Knee Osteoarthritis.
    Yokota N; Hattori M; Ohtsuru T; Otsuji M; Lyman S; Shimomura K; Nakamura N
    Am J Sports Med; 2019 Sep; 47(11):2577-2583. PubMed ID: 31373830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety, tolerability, clinical, and joint structural outcomes of a single intra-articular injection of allogeneic mesenchymal precursor cells in patients following anterior cruciate ligament reconstruction: a controlled double-blind randomised trial.
    Wang Y; Shimmin A; Ghosh P; Marks P; Linklater J; Connell D; Hall S; Skerrett D; Itescu S; Cicuttini FM
    Arthritis Res Ther; 2017 Aug; 19(1):180. PubMed ID: 28768528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intra-articular injection of expanded autologous bone marrow mesenchymal cells in moderate and severe knee osteoarthritis is safe: a phase I/II study.
    Al-Najar M; Khalil H; Al-Ajlouni J; Al-Antary E; Hamdan M; Rahmeh R; Alhattab D; Samara O; Yasin M; Abdullah AA; Al-Jabbari E; Hmaid D; Jafar H; Awidi A
    J Orthop Surg Res; 2017 Dec; 12(1):190. PubMed ID: 29233163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of adult human bone marrow-derived, cultured, pooled, allogeneic mesenchymal stromal cells (Stempeucel®): preclinical and clinical trial in osteoarthritis of the knee joint.
    Gupta PK; Chullikana A; Rengasamy M; Shetty N; Pandey V; Agarwal V; Wagh SY; Vellotare PK; Damodaran D; Viswanathan P; Thej C; Balasubramanian S; Majumdar AS
    Arthritis Res Ther; 2016 Dec; 18(1):301. PubMed ID: 27993154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intra-articular knee implantation of autologous bone marrow-derived mesenchymal stromal cells in rheumatoid arthritis patients with knee involvement: Results of a randomized, triple-blind, placebo-controlled phase 1/2 clinical trial.
    Shadmanfar S; Labibzadeh N; Emadedin M; Jaroughi N; Azimian V; Mardpour S; Kakroodi FA; Bolurieh T; Hosseini SE; Chehrazi M; Niknejadi M; Baharvand H; Gharibdoost F; Aghdami N
    Cytotherapy; 2018 Apr; 20(4):499-506. PubMed ID: 29428486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 63.